National Guideline for the Clinical Management of Opioid Use Disorder - CRISM

The guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.

Previous
Previous

Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome

Next
Next

The Pharmacotherapy of Chronic Pain: A Review